Capromorelin increases plasma GH levels in an anesthesized rat model, with an ED50 value less than 0.05 mg/kg iv[1].
Capromorelin shows enhanced intestinal absorption in rodent models and exhibited superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%][1].
